The impact of genotype on outcomes in individuals with Duchenne muscular dystrophy: A systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of genotype on outcomes in individuals with Duchenne muscular dystrophy: A systematic review
Authors
Keywords
-
Journal
MUSCLE & NERVE
Volume 65, Issue 3, Pages 266-277
Publisher
Wiley
Online
2021-12-08
DOI
10.1002/mus.27463
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy
- (2020) Pietro Spitali et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy
- (2020) Mariko Okubo et al. HUMAN GENETICS
- Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
- (2020) Diane E. Frank et al. NEUROLOGY
- Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
- (2020) Eugenio Mercuri et al. Journal of Comparative Effectiveness Research
- The ACTN3 577XX null genotype is associated with low left ventricular dilation-free survival rate in patients with Duchenne muscular dystrophy
- (2020) Masashi Nagai et al. JOURNAL OF CARDIAC FAILURE
- Cumulative jerk as an outcome measure in nonambulatory Duchenne muscular dystrophy
- (2019) Tatsuya Fujii et al. BRAIN & DEVELOPMENT
- Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy
- (2019) Lindsay N. Alfano et al. MEDICINE
- Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
- (2019) Claudia Brogna et al. PLoS One
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Amelioration of intracellular Ca2+ regulation by exon-45 skipping in Duchenne muscular dystrophy-induced pluripotent stem cell-derived cardiomyocytes
- (2019) Mitsuto Sato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Relationships between DMD mutations and neurodevelopment in dystrophinopathy
- (2019) Mathula Thangarajh et al. NEUROLOGY
- DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype
- (2018) Richard T. Wang et al. HUMAN MUTATION
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
- (2018) N. Doorenweerd et al. NEUROMUSCULAR DISORDERS
- A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
- (2018) Nathalie Goemans et al. NEUROMUSCULAR DISORDERS
- Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy
- (2018) Craig M. McDonald et al. Annals of Clinical and Translational Neurology
- Cardiopulmonary phenotypic discordance is common in Duchenne muscular dystrophy
- (2018) Justin B. Jin et al. PEDIATRIC PULMONOLOGY
- Off-Label Use of Ataluren in Four Non-ambulatory Patients With Nonsense Mutation Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength
- (2018) Daniel Ebrahimi-Fakhari et al. Frontiers in Pediatrics
- CARE guidelines for case reports: explanation and elaboration document
- (2017) David S. Riley et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Craig M McDonald et al. LANCET
- Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids
- (2017) Nathalie Goemans et al. NEUROMUSCULAR DISORDERS
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- The importance of genetic diagnosis for Duchenne muscular dystrophy
- (2016) Annemieke Aartsma-Rus et al. JOURNAL OF MEDICAL GENETICS
- Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up
- (2016) Anne M. Connolly et al. MUSCLE & NERVE
- DMDgenotypes and loss of ambulation in the CINRG Duchenne Natural History Study
- (2016) Luca Bello et al. NEUROLOGY
- Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy
- (2016) Jean-Yves Hogrel et al. NEUROLOGY
- Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study
- (2015) Luca Bello et al. ANNALS OF NEUROLOGY
- Modifier genes and their effect on Duchenne muscular dystrophy
- (2015) Andy H. Vo et al. CURRENT OPINION IN NEUROLOGY
- Six-minute walk test versus two-minute walk test in children with Duchenne muscular dystrophy: Is more time more information?
- (2015) Katharina Vill et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy
- (2015) Rudaina Banihani et al. JOURNAL OF CHILD NEUROLOGY
- Duchenne muscular dystrophy
- (2015) Eppie M Yiu et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy
- (2015) Nicolas Wein et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study
- (2015) Daniela Chieffo et al. PLoS One
- Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
- (2015) Milic V. Rasic et al. Balkan Journal of Medical Genetics
- Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial
- (2015) Andreea Mihaela Seferian et al. PLoS One
- Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
- (2015) Andrea Barp et al. PLoS One
- Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
- (2014) Thomas Voit et al. LANCET NEUROLOGY
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- (2014) Katharine Bushby et al. MUSCLE & NERVE
- 6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes
- (2014) Marika Pane et al. PLoS One
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Association Between Loss of Dp140 and Cognitive Impairment in Duchenne and Becker Dystrophies
- (2013) T Chamova et al. Balkan Journal of Medical Genetics
- THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study
- (2013) Craig M. Mcdonald et al. MUSCLE & NERVE
- P.2.7 6min walk test 12month changes in DMD: Correlation with genotype
- (2013) M. Pane et al. NEUROMUSCULAR DISORDERS
- LTBP4genotype predicts age of ambulatory loss in duchenne muscular dystrophy
- (2012) Kevin M. Flanigan et al. ANNALS OF NEUROLOGY
- Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
- (2012) L. Bello et al. NEUROLOGY
- The dystrophin–glycoprotein complex in brain development and disease
- (2012) Adrian Waite et al. TRENDS IN NEUROSCIENCES
- Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing
- (2011) Francesca Magri et al. BMC Medical Genetics
- Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up
- (2011) Francesca Magri et al. JOURNAL OF NEUROLOGY
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurocognitive Profiles in Duchenne Muscular Dystrophy and Gene Mutation Site
- (2011) Maria Grazia D’Angelo et al. PEDIATRIC NEUROLOGY
- DELETION STATUS AND INTELLECTUAL IMPAIRMENT IN DUCHENNE MUSCULAR DYSTROPHY
- (2010) K. M. D. Bushby et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy
- (2010) Kevin Wingeier et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Dystrophin Isoform Induction In Vivo by Antisense-mediated Alternative Splicing
- (2010) Sue Fletcher et al. MOLECULAR THERAPY
- Ventilatory parameters and maximal respiratory pressure changes with age in Duchenne muscular dystrophy patients
- (2010) Jerome Gayraud et al. PEDIATRIC PULMONOLOGY
- Dystrophin Gene Mutation Location and the Risk of Cognitive Impairment in Duchenne Muscular Dystrophy
- (2010) Peter J. Taylor et al. PLoS One
- Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression
- (2009) F. Daoud et al. HUMAN MOLECULAR GENETICS
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation